Author: Chandorkar, Aditya; Coro, Ana; Natori, Yoichiro; Anjan, Shweta; Abbo, Lilian M.; Guerra, Giselle; Mattiazzi, Adela D.; Mendezâ€Castaner, Lumen A.; Morris, Michele I.; Camargo, Jose F.; Vianna, Rodrigo; Simkins, Jacques
Title: Kidney transplantation during coronavirus 2019 pandemic at a large hospital in Miami Cord-id: y0wp77mw Document date: 2020_8_2
ID: y0wp77mw
Snippet: BACKGROUND: Coronavirus 2019 (COVIDâ€19) pandemic has resulted in more than 350 000 deaths worldwide. The number of kidney transplants has declined during the pandemic. We describe our deceased donor kidney transplantation (DDKT) experience during the pandemic. METHODS: A retrospective study was conducted to evaluate the safety of DDKT during the COVIDâ€19 pandemic. Multiple preventive measures were implemented. Adult patients that underwent DDKT from 3/1/20 to 4/30/20 were included. COVIDâ€1
Document: BACKGROUND: Coronavirus 2019 (COVIDâ€19) pandemic has resulted in more than 350 000 deaths worldwide. The number of kidney transplants has declined during the pandemic. We describe our deceased donor kidney transplantation (DDKT) experience during the pandemic. METHODS: A retrospective study was conducted to evaluate the safety of DDKT during the COVIDâ€19 pandemic. Multiple preventive measures were implemented. Adult patients that underwent DDKT from 3/1/20 to 4/30/20 were included. COVIDâ€19 clinical manifestations from donors and recipients, and postâ€transplant outcomes (COVIDâ€19 infections, readmissions, allograft rejection, and mortality) were obtained. The kidney transplant (KT) recipients were followed until 5/31/20. RESULTS: Seventyâ€six patients received kidneys from 57 donors. Fever, dyspnea, and cough were reported in 1, 2, and 1 donor, respectively. Thirtyâ€eight (66.6%) donors were tested for Severe Acute Respiratory Syndrome Coronavirus 2 (SARSâ€CoV2) prior to donation (mainly by nasopharyngeal or bronchoalveolar lavage polymerase chain reaction [PCR]) and 36 (47.3%) KT recipients were tested at the time of DDKT by nasopharyngeal PCR; all of these were negative. Our recipients were followed for a median of 63 (range: 33â€91) days. A total of 42 (55.3%) recipients were tested postâ€transplant for SARSâ€CoV2 by nasopharyngeal PCR including 12 patients that became symptomatic; all tests were negative except for one that was inconclusive, but it was repeated and came back negative. Forty (52.6%) KT recipients were readmitted, and 7 (9.2%) had biopsyâ€proven rejection during the followâ€up. None of the KT recipients transplanted during this period died. CONCLUSIONS: Our cohort demonstrated that DDKT can be safely performed during the COVIDâ€19 pandemic when preventive measures are implemented.
Search related documents:
Co phrase search for related documents- abdominal pain and acute respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and adequate personal protection: 1
- abdominal pain and admission require: 1, 2, 3
- abdominal pain and low threshold: 1, 2, 3, 4
- abnormal cxr and acute respiratory: 1, 2, 3, 4, 5, 6, 7
- abnormal cxr and acute respiratory illness: 1
- active remain and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory and additional measure: 1, 2, 3, 4, 5, 6
- acute respiratory and adequate personal protection: 1, 2, 3, 4, 5, 6
- acute respiratory and admission require: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68
- acute respiratory and local testing capacity: 1
- acute respiratory and long term dialysis: 1, 2
- acute respiratory and low threshold: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- acute respiratory illness and admission require: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date